Wilmington Savings Fund Society’s Novo Nordisk NVO Stock Holding History

Wilmington Savings Fund Society’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$551K	Sell	11,489 -290	-2%	-$12.5K	0.01%	402
2026 Q1	$433K	Hold	11,779	–	–	0.01%	439
2025 Q4	$599K	Hold	11,779	–	–	0.01%	390
2025 Q3	$654K	Sell	11,779 -7,116	-38%	-$417K	0.02%	361
2025 Q2	$1.3M	Buy	18,895 +1,562	+9%	+$106K	0.02%	380
2025 Q1	$1.2M	Sell	17,333 -2,548	-13%	-$210K	0.02%	387
2024 Q4	$1.71M	Sell	19,881 -9,118	-31%	-$986K	0.03%	326
2024 Q3	$3.45M	Buy	28,999 +13,437	+86%	+$1.79M	0.06%	227
2024 Q2	$2.22M	Sell	15,562 -476	-3%	-$63.1K	0.09%	162
2024 Q1	$2.06M	Buy	+16,038	New	+$1.91M	0.08%	171
2023 Q3	$1.44M	Sell	15,806 -292	-2%	-$25.7K	0.06%	180
2023 Q2	$1.3M	Sell	16,098 -1,844	-10%	-$151K	0.05%	190
2023 Q1	$1.43M	Sell	17,942 -412	-2%	-$29.2K	0.06%	177
2022 Q4	$1.24M	Hold	18,354	–	–	0.06%	189
2022 Q3	$914K	Buy	18,354 +3,258	+22%	+$175K	0.04%	207
2022 Q2	$841K	Sell	15,096 -20,266	-57%	-$1.12M	0.04%	219
2022 Q1	$1.96M	Sell	35,362 -524	-1%	-$26.9K	0.08%	178
2021 Q4	$2.01M	Sell	35,886 -224	-0.6%	-$12.1K	0.07%	176
2021 Q3	$1.73M	Hold	36,110	–	–	0.07%	184
2021 Q2	$1.51M	Sell	36,110 -802	-2%	-$31.1K	0.06%	202
2021 Q1	$1.24M	Sell	36,912 -1,958	-5%	-$69.7K	0.05%	210
2020 Q4	$1.36M	Hold	38,870	–	–	0.06%	199
2020 Q3	$1.35M	Sell	38,870 -260	-0.7%	-$8.67K	0.06%	193
2020 Q2	$1.28M	Hold	39,130	–	–	0.06%	192
2020 Q1	$1.18M	Sell	39,130 -916	-2%	-$27.3K	0.07%	183
2019 Q4	$1.16M	Sell	40,046 -830	-2%	-$23K	0.06%	180
2019 Q3	$1.06M	Buy	40,876 +2,224	+6%	+$56.2K	0.06%	180
2019 Q2	$987K	Hold	38,652	–	–	0.05%	187
2019 Q1	$1.01M	Hold	38,652	–	–	0.06%	184
2018 Q4	$890K	Hold	38,652	–	–	0.05%	187
2018 Q3	$911K	Buy	38,652 +500	+1%	+$12.2K	0.05%	202
2018 Q2	$879K	Sell	38,152 -428	-1%	-$10.2K	0.05%	204
2018 Q1	$950K	Hold	38,580	–	–	0.05%	204
2017 Q4	$1.04M	Hold	38,580	–	–	0.06%	201
2017 Q3	$929K	Hold	38,580	–	–	0.05%	208
2017 Q2	$828K	Sell	38,580 -2,278	-6%	-$46K	0.05%	214
2017 Q1	$700K	Sell	40,858 -118	-0.3%	-$2.06K	0.04%	218
2016 Q4	$735K	Hold	40,976	–	–	0.05%	214
2016 Q3	$852K	Sell	40,976 -1,000	-2%	-$24.8K	0.05%	211
2016 Q2	$1.13M	Sell	41,976 -1,634	-4%	-$44.8K	0.07%	200
2016 Q1	$1.18M	Sell	43,610 -300	-0.7%	-$8.04K	0.08%	196
2015 Q4	$1.27M	Sell	43,910 -200	-0.5%	-$5.54K	0.08%	193
2015 Q3	$1.2M	Sell	44,110 -1,000	-2%	-$28.3K	0.08%	196
2015 Q2	$1.24M	Sell	45,110 -40	-0.1%	-$1.12K	0.07%	199
2015 Q1	$1.21M	Sell	45,150 -2,000	-4%	-$46.1K	0.07%	200
2014 Q4	$998K	Sell	47,150 -1,600	-3%	-$35.7K	0.06%	217
2014 Q3	$1.16M	Sell	48,750 -1,200	-2%	-$27.6K	0.07%	213
2014 Q2	$1.15M	Sell	49,950 -2,800	-5%	-$61.8K	0.06%	218
2014 Q1	$1.2M	Buy	52,750 +1,600	+3%	+$34.1K	0.07%	213
2013 Q4	$945K	Sell	51,150 -500	-1%	-$8.71K	0.05%	237
2013 Q3	$874K	Sell	51,650 -6,000	-10%	-$101K	0.05%	234
2013 Q2	$894K	Buy	+57,650	New	+$960K	0.06%	231

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wilmington Savings Fund Society's NVO Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Novo Nordisk (NVO) stake by 2.5% in Q2 2026, selling an estimated $12.5K and leaving 11,489 shares worth $551K. The position accounts for 0.01% of the portfolio, ranked #402.

Wilmington Savings Fund Society first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.45M in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Wilmington Savings Fund Society held 11,489 shares of Novo Nordisk worth $551K as of Q2 2026.
Wilmington Savings Fund Society sold 290 Novo Nordisk shares in Q2 2026, an estimated $12.5K.
Novo Nordisk made up 0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #402 holding.
Wilmington Savings Fund Society first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Wilmington Savings Fund Society's Novo Nordisk position peaked at $3.45M in Q3 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.